Stay updated on Safe Doses CX-2029 in Solid Tumors and DLBCL Clinical Trial

Sign up to get notified when there's something new on the Safe Doses CX-2029 in Solid Tumors and DLBCL Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Safe Doses CX-2029 in Solid Tumors and DLBCL Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The Study Locations section was updated with added site listings across multiple U.S. states and international districts (Jongno-gu, Seodaemun-gu, Manchester Greater), and several previously listed locations were removed. This follows revision v3.3.3.
    Difference
    2%
    Check dated 2025-12-24T12:15:35.000Z thumbnail image
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    No Change Detected
  4. Check
    34 days ago
    Change Detected
    Summary
    Revision label updated from v3.2.0 to v3.3.2; no study content or functionality changes. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2025-11-25T13:51:44.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    Removed the government funding notice about NIH operating status; core study details remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2025-11-18T07:24:14.000Z thumbnail image
  6. Check
    63 days ago
    Change Detected
    Summary
    The two screenshots show the same study page with only minor layout adjustments and an updated last-updated timestamp; there are no changes to eligibility criteria, primary or secondary outcomes, enrollment, or study status. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-10-27T20:54:36.000Z thumbnail image
  7. Check
    84 days ago
    Change Detected
    Summary
    Added a government-status notice, confirmed NIH Clinical Center is open, added new condition 'Malignant lymphoma, large B-cell, diffuse' and revision v3.2.0; removed 'Carcinoma of esophagus' and revision v3.1.0.
    Difference
    5%
    Check dated 2025-10-06T07:51:17.000Z thumbnail image
  8. Check
    92 days ago
    Change Detected
    Summary
    Version upgraded to v3.1.0 with removal of the term 'Diffuse large b-cell lymphoma'.
    Difference
    0.3%
    Check dated 2025-09-29T04:11:34.000Z thumbnail image

Stay in the know with updates to Safe Doses CX-2029 in Solid Tumors and DLBCL Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Safe Doses CX-2029 in Solid Tumors and DLBCL Clinical Trial page.